Welcome to
National Cancer Center Korea

NCC Profile

icon

About Us

Board of Director

member4

Dr. KIM, Young Woo

Director, Research Institute
member4

Dr. EOM, Hyeon Seok

Director, Hospital
member4

Dr. MYUNG, Seung Kwon

Dean, NCC Graduate School of Cancer Science and Policy
member4

Dr. YOO, Chong Woo

Director, Office of Public Relations and Collaboration

Vision

The World’s Best National Cancer Center

Mission

Protecting people from cancer, and Enhancing the Quality of life of Cancer Patients

History

No YEAR EVENT
1 2000 National Cancer Center Act Enacted
2 2000 Clinical Care Services Started
3 2002 National Screening Program for 5 common cancers in Korea Developed
4 2005 Research Building Completed
5 2005 Designated as a WHO Collaborating Center (re-designated every 4 years)
6 2005 National Cancer Control Research Institute Opened
7 2007 Proton Beam Therapy Started
8 2007 National Cancer Prevention & Detection Building Opened
9 2009 GMP Facility for Immune Cell Therapeutics Opened
10 2011 Status Promotion of National Cancer Control Institute
11 2014 National Cancer Center- Graduate School of Cancer Science and Policy Opened

Event

shape1
shape3

Department

icon

Department

Name:Research Institute
Location:Goyang-si, Korea
Date of establishment:2005
Organization Type : Departments (1)
Number of beds:NA
Total number of staff:43 staff doctors 44 scientists 10 administrative and management staffs 9 technicians
Name:Hospital
Location:Goyang-si, Korea
Date of establishment:2000
Organization Type : Departments (2)
Number of beds:560
Total number of staff:103 staff doctor 847 nurses 28 pharmacists 223 health service staffs 6 medical physicist 89 administrative and management staffs 32 technicians
Name:National Cancer Control Institute
Location:Goyang-si, Korea
Date of establishment:2000
Organization Type : Departments (3)
Number of beds:NA
Total number of staff:6 staff doctors 18 scientists 1 nurses 8 administrative and management staffs 137 project assistants
Name:National Cancer Center-Graduate School of Cancer Science and Control
Location:Goyang-si, Korea
Date of establishment:2014
Organization Type : Departments (4)
Total number of staff:18 Professors 6 administrative and management staffs

Key Activities

icon
NO ACTIVITIES DEPARTMENT
1 Conducting and Offering Assistance to
Cancer Research
Research Institute
2 Diagnosing and Treating Cancer
Patients
Hospital
3 Assisting in the National Cancer Control
Initiatives
National Cancer Control Institute
4 Educating and Training Cancer
Specialists

NCC-Graduate School of Cancer Science and

Policy

Key Research

icon
NO RESEARCH FIELDS RESEARCH COLLABORATORS

1

Operation of Core for Cancer
Proteogenomics Analysis

 
2 Research on Next Generation-Precision
Medical of Lung Cancer
 
3 Research on Effect of Helicobacter pylori Eradication on Gastric Cancer
Prevention in Korea
 International Agency for Research on Cancer
4 Operation of Biobank  
5 Operation of Laboratory Animal
Research Facility and Building Animal
Model for Cancer Research
 

Cancer Profile

icon
Total Population 51,400,000
Income Group High
Total Deaths 248,000
Life Expectancy at birth Total 84
Male 81
Female 87
Cancer Mortality Profile
Age-Standardized Cancer Mortality Trends
Cancer Incidence
Adult Risk Factors Current tobacco smoking (2011 Data) Males NA
Females NA
Total NA
Total alcohol per capita consumption, in litres of pure alcohol (2010 Data) Males 21.0
Females 3.9
Total 12.3
Physical inactivity (2010 Data) Males 29.4%
Females 39.7%
Total 34.7%
Obesity (2014 Data) Males 46.3%
Females 26.9%
Totals 37.1%
Household solid fuel use (2012 Data) Males NA
Females NA
Total 0.0%
Cancer Plans, Monitoring, and Surveillance Has an operational cancer policy/strategy/action plan Yes
Has a cancer registry    
Scope Hospital-based
Coverage National
Last Year of Data 2020
Cancer Primary Prevention Policies Tobacco Control Has an operational policy, strategy or action plan to reduce the burden of tobacco use Yes
Smoke-free legislation Up to two public places completely smoke-free
Tobacco dependence treatment National quit line, and both NRT and some cessation services costcovered*
Warning labels Medium size warnings missing some appropriate characteristics OR large warnings missing many appropriate characteristics
Bans on advertising, promotion and sponsorship Complete absence of ban, or ban that does not cover national television, radio and print media
Tobacco taxes 51–75% of retail price is tax
Overweight and obesity prevention and control Has an operational policy, strategy or action plan for reducing overweight/obesity Yes
Physical inactivity prevention and control Has an operational policy, strategy or action plan to reduce physical inactivity and/or promote physical activity Yes
Harmful use of alcohol prevention and control Has an operational policy, strategy or action plan to reduce the harmful use of alcohol Yes
National Immunization Human Papillomavirus vaccination schedule NA
Hepatitis B vaccination schedule Birth, +1 month, +6 months
Hepatitis B vaccination coverage, infants 99%
Cancer Screening and Early Detection Cervical Cancer Cervical cytology (PAP) Generally available at the public primary health care level
Acetic Acid Vizualization (VIA) Generally available at the public primary health care level
Breast Cancer Breast palpation / clinical breast exam (CBE) Generally available at the public primary health care level
Mammogram Generally available at the public primary health care level
Colorectal Cancer Faecal occult blood test or faecal immunological test Generally available at the public primary health care level
Bowel cancer screening by exam or colonoscopy Generally available at the public primary health care level
Cancer Treatment and Palliative Care Radiotherapy Generally available in the public health system
Total high energy teletherapy units / million inhabitants 3
Number of radiotherapy centres 63
Number of radiation oncologists 144
Chemotherapy (medicines not specified) Generally available in the public health system
Oral morphine (formulation not specified) Not generally available in the public health system
Non-methadone morphine equivalent consumption per cancer death (mg) 28,897.0
Community/home care for people with advanced stage cancer and other NCDs Not generally available
REMARKS
SOURCE Extracted from: WHO Cancer Country Profiles 2014 (https://www.who.int/cancer/country-profiles/kor_en.pdf?ua=1) as of 2019/05/30
shape1
shape2

Stay connect with us

icon

Please complete the form below to send us an E-Mail. For security and anti-spam purposes, we do not post our E-Mail addresses on our website.